Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
Craig FF, Thomas KS, Mitchell EJ, Williams HC, Norrie J, Mason JM, Ormerod AD; UK Dermatology Clinical Trials Network’s STOP GAP Trial Team. Craig FF, et al. Among authors: ormerod ad. Trials. 2012 Apr 28;13:51. doi: 10.1186/1745-6215-13-51. Trials. 2012. PMID: 22540770 Free PMC article. Clinical Trial.
Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study.
Thomas KS, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell E, Mason JM, Johnston GA, Wahie S, Williams HC; UK Dermatology Clinical Trials Network's STOP GAP Team. Thomas KS, et al. Among authors: ormerod ad. J Am Acad Dermatol. 2016 Nov;75(5):940-949. doi: 10.1016/j.jaad.2016.06.016. Epub 2016 Aug 5. J Am Acad Dermatol. 2016. PMID: 27502313
Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum?
Wilkes SR, Williams HC, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell EJ, Mason JM, Thomas KS; United Kingdom Dermatology Clinical Trials Network STOP GAP team. Wilkes SR, et al. Among authors: ormerod ad. J Am Acad Dermatol. 2016 Dec;75(6):1216-1220.e2. doi: 10.1016/j.jaad.2016.07.049. Epub 2016 Oct 11. J Am Acad Dermatol. 2016. PMID: 27742168
Authors' reply to Elshimy.
Ormerod AD, Thomas KS. Ormerod AD, et al. BMJ. 2015 Sep 30;351:h5115. doi: 10.1136/bmj.h5115. BMJ. 2015. PMID: 26424744 No abstract available.
A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease.
Thomas KS, Batchelor JM, Bath-Hextall F, Chalmers JR, Clarke T, Crowe S, Delamere FM, Eleftheriadou V, Evans N, Firkins L, Greenlaw N, Lansbury L, Lawton S, Layfield C, Leonardi-Bee J, Mason J, Mitchell E, Nankervis H, Norrie J, Nunn A, Ormerod AD, Patel R, Perkins W, Ravenscroft JC, Schmitt J, Simpson E, Whitton ME, Williams HC. Thomas KS, et al. Among authors: ormerod ad. Southampton (UK): NIHR Journals Library; 2016 Dec. Southampton (UK): NIHR Journals Library; 2016 Dec. PMID: 27977093 Free Books & Documents. Review.
Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
Yiu ZZN, Smith CH, Ashcroft DM, Lunt M, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group. Yiu ZZN, et al. Among authors: ormerod ad. J Invest Dermatol. 2018 Mar;138(3):534-541. doi: 10.1016/j.jid.2017.10.005. Epub 2017 Oct 17. J Invest Dermatol. 2018. PMID: 29054603 Free PMC article.
Interventions for hidradenitis suppurativa.
Ingram JR, Woo PN, Chua SL, Ormerod AD, Desai N, Kai AC, Hood K, Burton T, Kerdel F, Garner SE, Piguet V. Ingram JR, et al. Among authors: ormerod ad. Cochrane Database Syst Rev. 2015 Oct 7;2015(10):CD010081. doi: 10.1002/14651858.CD010081.pub2. Cochrane Database Syst Rev. 2015. PMID: 26443004 Free PMC article. Review.
157 results